Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07401771 · ClinicalTrials.gov registry record

Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

A clinical trial of Heart Failure With Preserved Ejection Fraction, sponsored by Mayo Clinic.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT07401771: Recruiting study of Heart Failure With Preserved Ejection Fraction, sponsored by Mayo Clinic.

NCT07401771 is a study of Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 400 participants, below the 2,279-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07401771, a study of Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea.

Primary Outcome

Number of heart failure hospitalizations will be determined by the number of patients admitted to the hospital due to heart failure complications.

Interventions

  • DIAGNOSTIC_TEST Exercise Cardiovascular Magnetic Resonance

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2026-03
Est. Completion 2028-03
Mayo Clinic

2,844 total trials

What NCT07401771 shows while recruiting

NCT07401771 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 2,279-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Exercise Cardiovascular Magnetic Resonance is the first listed.

NCT07401771 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07401771 about?

NCT07401771 is a clinical study titled "Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction". The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea.

What is the current status of trial NCT07401771?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2026-03. Estimated completion is 2028-03.

What conditions does trial NCT07401771 study?

This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction.

What interventions are being tested in trial NCT07401771?

The interventions under investigation include: Exercise Cardiovascular Magnetic Resonance (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07401771?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07401771 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07401771's enrollment target sits among peer trials

400 9th of 42 higher than 34 of 42 other Heart Failure With Preserved Ejection Fraction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure With Preserved Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07401771, the US trial registry maintained by the National Library of Medicine. NCT07401771 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.